Thrivent Financial For Lutherans Vbi Vaccines Inc Transaction History

Thrivent Financial For Lutherans

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 19, 2021	SELL	$2.61 - $4.17 $825,044 - $1.32 Million	-316,109 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.91 - $4.32 $566,175 - $840,507	-194,562 Reduced 38.1%	316,109 $983,000
Q3 2020 Nov 10, 2020	BUY	$2.77 - $6.17 $787,530 - $1.75 Million	284,307 Added 125.6%	510,671 $1.46 Million
Q2 2020 Aug 12, 2020	BUY	$0.87 - $3.13 $196,936 - $708,519	226,364 New	226,364 $701,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.